Genetic Test for Mental Health: What It Can Show

A genetic report may show indicators related to depression, ADHD, cognitive function, Alzheimer's disease, or other features of brain function. The very fact that such an assessment exists immediately raises a difficult question: what exactly does it say about a specific person? Does a higher genetic predisposition mean that a certain condition already exists or will necessarily develop? And does a lower one mean there's nothing to worry about?

It's important to understand here that a genetic result doesn't function as a diagnosis or a prognosis. For most mental and cognitive traits, it provides information about hereditary predisposition estimated from genetic associations. A person's actual condition is shaped in a far more complex way: alongside genetic factors, age, life experience, environment, sleep, stress, other illnesses, medication use, and many other factors all matter. 

So the question shouldn't be framed as “will a DNA test show what's wrong with me?” In this article, we'll look at which types of indicators can be assessed from DNA, how their evidence base differs, how to read the results of such a test, and where the line runs between genetic context and clinical assessment.

What a Genetic Test for Mental Health Actually Measures

A DNA test doesn't assess a person's symptoms — it analyzes genetic variants that studies have linked to certain traits or conditions. Genome-wide association studies (GWAS) compare genetic data from a large number of people and identify statistical associations between genetic variants and a particular trait or condition. Most complex mental conditions have a polygenic architecture: a large number of genetic variants are linked to the predisposition, and their contribution is assessed collectively.

In practical interpretation, it's important not to conflate different levels. A genetic variant is a difference in DNA. Genetic predisposition is the contribution of genetic differences to the probability or variability of a particular trait; in a genetic test it is estimated from genetic association data. A symptom is something a person experiences or that can be observed. A clinical condition is determined by a combination of criteria, history, and context. One level cannot automatically substitute for another.

For many complex traits, a polygenic score (PRS) is used — a metric that aggregates the contribution of many genetic variants weighted by their effects in the original studies. PRS makes it possible to estimate a person's relative genetic predisposition compared with a reference population. At the same time, it is not a diagnostic threshold: the result depends on the specific model, the set of variants, and the population on which it was built, so a high PRS does not mean a disorder is present, and a low one does not rule it out (Mollon et al., Biol. Psychiatry, 2025).

What Features of the Psyche and Brain Function Can Be Assessed From Genetic Data

Genetic research covers different groups of traits related to the psyche and brain function. These include cognitive characteristics, such as memory and information-processing speed, predisposition to specific mental conditions, risks of neurodegenerative diseases, and certain emotional and behavioral traits. At the same time, these are very different indicators: they differ in the scale and quality of the underlying research, the number of genetic associations identified, and how confidently the results can be interpreted at the level of an individual person.

Even within a single group, closely related traits can have different genetic architectures. For example, studies of cognitive function show differences between information-processing speed and accuracy on cognitive tasks. So “cognitive abilities” shouldn't be treated as a single universal genetic indicator (Li et al., Nat. Commun., 2024).

A similar heterogeneity is seen for personality traits as well. In a large 2024 GWAS of the five Big Five traits, sample sizes ranged from 237,000 to 683,000 people, but the number of genetic loci identified varied substantially between traits. This shows that even indicators grouped under one psychological model can have very different amounts of accumulated genetic data (Gupta et al., Nat. Hum. Behav., 2024).

Why Genetic Results Are Interpreted Differently for Different Traits and Conditions

A genetic result can carry very different meaning for different conditions. This depends on how polygenic the trait is, whether individual variants exist with a relatively strong link to it, how large and reproducible the studies underlying the estimate are, and how well that data transfers to a specific population. So an indicator related to Alzheimer's disease shouldn't be interpreted by the same logic as a polygenic score for depression or a cognitive trait.

One of the best-known examples is APOE (apolipoprotein E). Variants of this gene have a well-studied link to the risk of late-onset Alzheimer's disease. In particular, the ε4 allele is associated with higher risk, but on its own it is not a diagnosis and does not mean the disease will necessarily develop. The strength of this link also differs between populations and depends on broader genetic context (Jackson et al., Nat. Rev. Neurol., 2024).

For most psychiatric conditions, the picture is different. Their genetic architecture is usually far more polygenic: a large number of variants are linked to the predisposition, and some genetic signals overlap between different disorders (Grotzinger et al., Nature, 2026).

One Gene Won't Explain Your Mood or a Mental Disorder

A common mistake is explaining mood or mental state through a single gene or a “neurotransmitter level.” First, dozens and hundreds of genes influence a psychological profile. Second, genotyping, which analyzes polymorphisms in these genes, does not measure the concentration of serotonin, dopamine, or norepinephrine in the brain and does not show the current activity of neurotransmitter systems. Genetic research can link variants to certain biological pathways and nervous system functions, but such a link does not make it possible to determine the current level of serotonin or dopamine in the brain from a genotype, or to reduce a mental state to a single neurotransmitter mechanism (Andreassen et al., World Psychiatry, 2023). 

For more on the difference between genetic data, neurotransmitter systems, and their actual activity, see Serotonin and Dopamine: What Actually Happens in the Brain.

What Besides Genetics Affects Mental State

Genetic predisposition is not a guaranteed scenario. Mental state and cognitive functioning are shaped by genetic and non-genetic factors, including life experience, environment, and other health and lifestyle features. Some of these influences can interact with genetic differences, so a similar genetic predisposition in different people does not mean the same clinical outcome (Herrera-Luis et al., Nat. Rev. Genet., 2024).

The reference population against which the polygenic result is interpreted matters separately. PRS accuracy can decrease if a person's genetic ancestry differs from that of the study participants the model was built on (Ding et al., Nature, 2023). That's exactly why a percentile shows the result's position relative to a defined reference group, not a percentage probability of developing the condition.

How to Relate a Genetic Result to Symptoms

If a person is already noticing difficulty concentrating, anxiety, mood changes, memory problems, or other symptoms, a genetic result can add information about the hereditary component of predisposition, but it does not determine the cause of these manifestations. For example, a higher genetic predisposition to ADHD may be part of the broader context, but on its own it does not mean that concentration difficulties are a manifestation of ADHD specifically. Likewise, a lower predisposition does not rule out a clinical condition.

The value of this data lies in the fact that it answers a different question: what is a person's genetic predisposition to a particular trait or condition compared with a reference population? Clinical assessment, in turn, helps determine which symptoms are present, when they started, how long they last, in which situations they appear, how much they affect everyday functioning, and what other causes might explain them. For complex mental conditions, these levels of information do not replace one another — they answer different questions.

That's why it makes sense to view a genetic result not as confirming or refuting symptoms, but as additional genetic context that can be weighed alongside history, clinical presentation, and other data. For more on this, using specific disorders as examples, see ADHD, OCD, and Panic Disorder: What Genetic Data Shows.

What's Included in the Apixmed Prism “Mental Health & Brain” Panel

The “Mental Health & Brain” panel brings together genetic indicators related to cognitive function, mental traits, and specific neurological risks. Each one is assessed separately, so the report doesn't reduce brain function and the psyche to a single, generalized score.

A genetic test can be useful if you want additional, stable context on brain function and mental traits, and want to understand the hereditary predispositions in your genetic profile.

The results of the “Mental Health & Brain” DNA test provide genetic context on specific cognitive, mental, and neurodegenerative indicators. If the goal is to assess current symptoms, memory, or concentration, establish a clinical status, or choose a treatment, the appropriate clinical, psychological, neurological, or laboratory methods are needed.

The most valuable outcome of a genetic test isn't a mark on a “high” or “low risk” scale, but a correct and clear level of information: what exactly was assessed, how strong the evidence behind the result is, and what its limits are. In this context, genetic data complements other health information without turning into a diagnosis or a prediction of the future.

The results of a genetic test are not a diagnosis and not a substitute for a doctor's consultation. The Apixmed Prism report provides genetic context that complements examination results and helps with making decisions together with a doctor.

Sources

1. Mollon J., Schultz L.M., Knowles E.E.M., Jacquemont S., Glahn D.C., Almasy L. Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit Their Clinical Utility. Biological Psychiatry. 2025;98(6):476–484. DOI: https://doi.org/10.1016/j.biopsych.2025.03.006

2. Grotzinger A.D. et al. Mapping the genetic landscape across 14 psychiatric disorders. Nature. 2026;649:406–415. DOI: https://doi.org/10.1038/s41586-025-09820-3

3. Li M., Dang X., Chen Y. et al. Cognitive processing speed and accuracy are intrinsically different in genetic architecture and brain phenotypes. Nature Communications. 2024;15:7786. DOI: https://doi.org/10.1038/s41467-024-52222-8

4. Gupta P., Galimberti M., Liu Y. et al. A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology. Nature Human Behaviour. 2024;8:2235–2249. DOI: https://doi.org/10.1038/s41562-024-01951-3

5. Jackson R.J., Hyman B.T., Serrano-Pozo A. Multifaceted roles of APOE in Alzheimer disease. Nature Reviews Neurology. 2024;20:457–474. DOI: https://doi.org/10.1038/s41582-024-00988-2

6. Ding Y. et al. Polygenic scoring accuracy varies across the genetic ancestry continuum. Nature. 2023;618:774–781. DOI: https://doi.org/10.1038/s41586-023-06079-4

7. Kullo I.J. Clinical use of polygenic risk scores: current status, barriers and future directions. Nature Reviews Genetics. 2026;27:246–263. DOI: https://doi.org/10.1038/s41576-025-00900-8

8. Andreassen O.A., Hindley G.F.L., Frei O., Smeland O.B. New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. World Psychiatry. 2023;22(1):4–24. DOI: https://doi.org/10.1002/wps.21034

9. Herrera-Luis E., Benke K., Volk H. et al. Gene–environment interactions in human health. Nature Reviews Genetics. 2024;25:768–784. DOI: https://doi.org/10.1038/s41576-024-00731-z